Results 221 to 230 of about 76,484 (243)

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Ophthalmology, 2020
Kristin Josic, Carl Baker, Jennifer K Sun   +2 more
exaly  

Diabetic Macular Edema: Pathogenesis and Treatment

Survey of Ophthalmology, 2009
Neelakshi Bhagat, Marco A Zarbin
exaly  

Mechanisms of macular edema: Beyond the surface

Progress in Retinal and Eye Research, 2018
Alejandra Daruich, Alexandre Matet, Alexandre Moulin   +2 more
exaly  

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology, 2014
Jean-François Korobelnik, Ursula M Schmidt-Erfurth, David S Boyer   +2 more
exaly  

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology, 2016
Lee M Jampol, Emily Y Chew, Michele Melia   +2 more
exaly  

The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Ophthalmology, 1984
Ronald Klein, David L Demets
exaly  

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Ophthalmology, 2015
Michael J Elman, Lee M Jampol
exaly  

Macular Edema

2017
Cynthia X. Qian, Lucia Sobrin
openaire   +2 more sources

Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions

Progress in Retinal and Eye Research, 2013
Ingeborg Klaassen
exaly  

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology, 2016
Jeffrey S Heier, Jean-François Korobelnik, Ursula M Schmidt-Erfurth   +2 more
exaly